Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China

Molecular and Cellular Biochemistry

Volumn 362, Issue 1-2, 2012, Pages 241-248

  Zeng, Xiangting ^a   Li, Yumin ^a   Liu, Tao ^a   Zhang, Junqiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Gastric cancer; H. pylori infection; High incidence; IL 10 promoter polymorphism

Indexed keywords

INTERLEUKIN 10; CYTOSINE; DNA; GUANINE; THIAMINE;

ADULT; AGED; ALLELE; ANTIBODY DETECTION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLOOD SAMPLING; CANCER RISK; CHINA; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROMOTER REGION; STOMACH CARCINOMA; CANCER GROWTH; NONHUMAN; PATHOGENESIS; STOMACH CANCER;

HELICOBACTER PYLORI;

ADULT; AGED; AGED, 80 AND OVER; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84857037632     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1149-y     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
2. Masoud A, Fanny J, Anton EK (2011) The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol 26:23-28
3. Henk H, Edwin PMJ, Nicole CTG, Cornelis JHV (2009) Gastric cancer. Lancet 374(9701):1594-1595
4. Yamaoka Y, Kato M, Asaka M (2008) Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 47:1077-1083
5. Peter H, Stephan G (2003) Gastric cancer. Lancet 362:305-315
6. Hocker M, Peter H (2003) Helicobacter pylori virulence factors- one part of a big picture. Lancet 362(9391):1231-1233 (Pubitemid 37255353)
7. Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus associated gastric carcinoma. J Infect Dis 185:106-109
8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8 (Pubitemid 27050850)
9. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082-1089 (Pubitemid 38961959)
10. Mitsushige S, Takahisa F, Naohito S, Akiko N, Masayoshi K, Haruhiko S, Akira H (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22:1443-1449
11. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354-362 (Pubitemid 43329250)
12. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735-6740 (Pubitemid 23006271)
13. Peek R M Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal adenocarcinomas. Nat Rev Cancer 2(1):28-37
14. Meira E, Xiao OS, Yong BX, Wong HC (2011) Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai women's and men's health studies. Am J Epidemiol 172(4):397-406
15. Hu JF, La Vecchia C, Morrison H (2011) Salt, processed meat and the risk of cancer. Eur J Cancer Prev 20(2):132-139
16. Siman JH, Forsgren A, Berglund G, Floren CH (2001) Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 36:208-213 (Pubitemid 32183434)
17. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH (2003) Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 125(6):1636-1644 (Pubitemid 37500427)
18. Yamaji Y, Watabe H, Yoshida H, Kawabe T, Wada R, Mitsushima T, Omata M (2009) High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors. Helicobacter 4(2):81-86
19. The Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359-1362
20. Konturek SJ, Starzynska T, Konturek PC, Karczewska E, Marlicz K, Lawniczak M, Jaroszewicz-Heigelman H, Bielanski W, Hartwich A, Ziemniak A, Hahn EG (2004) Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 37: 891-898
21. Kikuchi S, Crabtree JE, Forman D, Kurosawa M (1999) Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research group on prevention of gastric carcinoma among young adults. Am J Gastroenterol 94:3455-3459
22. Rieder G, Merchant J, Haas R (2005) Helicobacter pylori Cagtype IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128:1229-1242 (Pubitemid 40712175)
23. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 115(5):678-683
24. Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4(9):688-694 (Pubitemid 39215067)
25. Suerbaum S, Michetti P (2002) Helicobacter infection. N Engl J Med 347:1175-1186
26. Megraud F (2001) Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis 19:99-103 (Pubitemid 32823919)
27. Hynes RO (2002) Integrins bidirectional, allosteric signaling machines. Cell 110:673-687 (Pubitemid 35283958)
28. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516-523 (Pubitemid 44332916)
29. Blaser MJ, Berg DE (2001) H. pylori genetic diversity and risk of human disease. J Clin Invest 107:767-773 (Pubitemid 32274024)
30. Parsonnent J (1998) H pylori-the size of the problem. Gut 43(suppl 1):3247-3249
31. Gebert B, Fischer W, Haas R (2004) The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol 152:205-220 (Pubitemid 44404365)
32. Cover TL, Blanke SR (2005) Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 3:320-332 (Pubitemid 40443725)
33. Kamangar F, Abnet CC, Hutchinson AA (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer. Cancer Causes Control 17:117-125 (Pubitemid 43084810)
34. Suzuki S, Muroishi Y, Nakanishi I, Oda Y (2004) Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 39:220-230 (Pubitemid 38519426)
35. Kondo S, Shinomura Y, Kanayama S (1994) Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 267:G966-G971
36. Lee JY, Kim HY, Kim KH (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Let 225:207-214
37. Bai XL, Sun LP, Liu J, Chen W, Zhang Y, Yuan Y (2008) Correlation of interleukin-10-1082G/A single nucleotide polymorphism to the risk of gastric cancer in North China: a casecontrol study. Ai Zheng 27:35-40
38. El-Omar EM, Rabkin CS, Gammon MD (2003) Increased risk of non-cardia gastric cancer associated with pro-inflammatory cytokine gene polymorphisms. Gastroenterology 124:1193-1201 (Pubitemid 36531795)
39. Zambon CF, Basso D, Navaglia F (2005) Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29:141-152 (Pubitemid 40126232)
40. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM (1999) Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94:3941-3946
41. Schaaf BM, Boehmke F, Esnaashari (2003) H pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 168: 476-480 (Pubitemid 37046878)
42. Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W (2009) PARP-1 Val762 Ala polymorphism CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 36(6):1461-1467
43. Konturek PC, Rembiasz K, Konturek SJ, Stachura J, Bielanski W, Galuschka K, Karcz D, Hahn EG (2003) Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci 48:36-46 (Pubitemid 36232760)